Advertisement
New Zealand markets closed
  • NZX 50

    11,796.21
    -39.83 (-0.34%)
     
  • NZD/USD

    0.5885
    -0.0020 (-0.34%)
     
  • NZD/EUR

    0.5526
    -0.0018 (-0.33%)
     
  • ALL ORDS

    7,817.40
    -81.50 (-1.03%)
     
  • ASX 200

    7,567.30
    -74.80 (-0.98%)
     
  • OIL

    83.20
    +0.47 (+0.57%)
     
  • GOLD

    2,406.60
    +8.60 (+0.36%)
     
  • NASDAQ

    17,088.57
    -305.74 (-1.76%)
     
  • FTSE

    7,895.85
    +18.80 (+0.24%)
     
  • Dow Jones

    37,856.85
    +81.47 (+0.22%)
     
  • DAX

    17,737.36
    -100.04 (-0.56%)
     
  • Hang Seng

    16,224.14
    -161.73 (-0.99%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     
  • NZD/JPY

    90.9570
    -0.2970 (-0.33%)
     

Global OTC Hyaluronic Acid Market 2022 to 2027 - Featuring Anika Therapeutics, Contipro, Galderma and LG Life Sciences Among Others

Company Logo
Company Logo

Global OTC Hyaluronic Acid Market

Global OTC Hyaluronic Acid Market
Global OTC Hyaluronic Acid Market

Dublin, Feb. 02, 2023 (GLOBE NEWSWIRE) -- The "Global OTC Hyaluronic Acid Market (2022-2027) by Type, Applications, and Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis" report has been added to ResearchAndMarkets.com's offering.

The Global OTC Hyaluronic Acid Market is estimated to be USD 4.3 Bn in 2022 and is expected to reach USD 6.2 Bn by 2027, growing at a CAGR of 7.6%.

Market Dynamics

Market dynamics are forces that impact the prices and behaviors of the Global OTC Hyaluronic Acid Market stakeholders. These forces create pricing signals which result from the changes in the supply and demand curves for a given product or service. Forces of Market Dynamics may be related to macro-economic and micro-economic factors.

ADVERTISEMENT

There are dynamic market forces other than price, demand, and supply. Human emotions can also drive decisions, influence the market, and create price signals.

As the market dynamics impact the supply and demand curves, decision-makers aim to determine the best way to use various financial tools to stem various strategies for speeding growth and reducing risks.

Competitive Quadrant

The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Ansoff Analysis

The report presents a detailed Ansoff matrix analysis for the Global OTC Hyaluronic Acid Market. Ansoff Matrix, also known as the Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.

The analyst analyses the Global OTC Hyaluronic Acid Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.

Based on the SWOT analysis conducted on the industry and industry players, the analyst has devised suitable strategies for market growth.

Why buy this report?

  • The report offers a comprehensive evaluation of the Global OTC Hyaluronic Acid Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.

  • The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.

  • The report includes an in-depth market analysis using Porter's 5 forces model and the Ansoff Matrix. In addition, the impact of Covid-19 on the market is also featured in the report.

  • The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.

  • The report also contains a competitive analysis using Positioning Quadrants, the analyst's competitive positioning tool.

Key Topics Covered:

1 Report Description

2 Research Methodology

3 Executive Summary

4 Market Dynamics
4.1 Drivers
4.1.1 Adoption of Nonsurgical Cosmetic Procedures
4.1.2 Growing Demand Viscosupplementation for Osteoarthritis Treatment
4.2 Restraints
4.2.1 Risk of Side Effects of Hyaluronic Acid
4.3 Opportunities
4.3.1 Wide Application in Anti-Aging Processes
4.3.2 Growing Approval and Launch of New Cosmetic Products
4.4 Challenges
4.4.1 Increasing Concern Regarding Efficacy of Viscosupplementation Products

5 Market Analysis
5.1 Regulatory Scenario
5.2 Porter's Five Forces Analysis
5.3 Impact of COVID-19
5.4 Ansoff Matrix Analysis
5.5 PESTLE Analysis

6 Global OTC Hyaluronic Acid Market, By Type
6.1 Introduction
6.2 Five Injection
6.3 Single Injection
6.4 Three Injection

7 Global OTC Hyaluronic Acid Market, By Applications
7.1 Introduction
7.2 Dermal Fillers
7.3 Ophthalmic
7.4 Osteoarthritis
7.5 Vesicoureteral Reflux

8 Americas' OTC Hyaluronic Acid Market
8.1 Introduction
8.2 Argentina
8.3 Brazil
8.4 Canada
8.5 Chile
8.6 Colombia
8.7 Mexico
8.8 Peru
8.9 United States
8.10 Rest of Americas

9 Europe's OTC Hyaluronic Acid Market
9.1 Introduction
9.2 Austria
9.3 Belgium
9.4 Denmark
9.5 Finland
9.6 France
9.7 Germany
9.8 Italy
9.9 Netherlands
9.10 Norway
9.11 Poland
9.12 Russia
9.13 Spain
9.14 Sweden
9.15 Switzerland
9.16 United Kingdom
9.17 Rest of Europe

10 Middle East and Africa's OTC Hyaluronic Acid Market
10.1 Introduction
10.2 Egypt
10.3 Israel
10.4 Qatar
10.5 Saudi Arabia
10.6 South Africa
10.7 United Arab Emirates
10.8 Rest of MEA

11 APAC's OTC Hyaluronic Acid Market
11.1 Introduction
11.2 Australia
11.3 Bangladesh
11.4 China
11.5 India
11.6 Indonesia
11.7 Japan
11.8 Malaysia
11.9 Philippines
11.10 Singapore
11.11 South Korea
11.12 Sri Lanka
11.13 Thailand
11.14 Taiwan
11.15 Rest of Asia-Pacific

12 Competitive Landscape
12.1 IGR Competitive Quadrant
12.2 Market Share Analysis
12.3 Strategic Initiatives
12.3.1 M&A and Investments
12.3.2 Partnerships and Collaborations
12.3.3 Product Developments and Improvements

13 Company Profiles
13.1 Anika therapeutics
13.2 Contipro a.s.
13.3 Ferring B.V
13.4 Galderma SA
13.5 HTL Biotechnology
13.6 LG Life Sciences
13.7 Lifecore Biomedical, Inc.
13.8 Maruha Nichiro, Inc.
13.9 Salix Pharmaceuticals, Inc.
13.10 Sanofi SA
13.11 Seikagaku Corp.
13.12 Shiseido Company, Ltd.
13.13 Smith & Nephew PLC
13.14 Zimmer Biomet

14 Appendix

For more information about this report visit https://www.researchandmarkets.com/r/4vl92v-otc?w=12

Attachment

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900